Pro-Dex, Inc. (NASDAQ:PDEX – Get Free Report) shares crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $47.21 and traded as high as $66.20. Pro-Dex shares last traded at $61.98, with a volume of 61,296 shares trading hands.
Analysts Set New Price Targets
Several brokerages have recently issued reports on PDEX. Ascendiant Capital Markets boosted their price target on shares of Pro-Dex from $56.00 to $70.00 and gave the company a “buy” rating in a report on Tuesday, May 12th. Weiss Ratings reissued a “hold (c+)” rating on shares of Pro-Dex in a report on Friday, May 1st. Finally, Zacks Research raised shares of Pro-Dex to a “hold” rating in a report on Tuesday, May 19th. One equities research analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, Pro-Dex has a consensus rating of “Hold” and an average target price of $70.00.
View Our Latest Stock Report on Pro-Dex
Pro-Dex Stock Down 1.1%
Pro-Dex (NASDAQ:PDEX – Get Free Report) last posted its quarterly earnings data on Thursday, April 30th. The medical instruments supplier reported $1.20 earnings per share for the quarter, topping the consensus estimate of $0.62 by $0.58. The business had revenue of $19.95 million during the quarter, compared to the consensus estimate of $17.90 million. Pro-Dex had a net margin of 16.08% and a return on equity of 22.78%. On average, sell-side analysts expect that Pro-Dex, Inc. will post 3.16 EPS for the current fiscal year.
Insider Buying and Selling
In other Pro-Dex news, CEO Kirk Richard Lee Van, Jr. sold 4,128 shares of the company’s stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $62.36, for a total value of $257,422.08. Following the completion of the sale, the chief executive officer directly owned 89,707 shares of the company’s stock, valued at approximately $5,594,128.52. This represents a 4.40% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 45.90% of the company’s stock.
Institutional Investors Weigh In On Pro-Dex
A number of institutional investors and hedge funds have recently bought and sold shares of PDEX. Los Angeles Capital Management LLC acquired a new stake in Pro-Dex in the 4th quarter valued at about $37,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in Pro-Dex in the 2nd quarter valued at about $50,000. AlphaQuest LLC acquired a new stake in Pro-Dex in the 3rd quarter valued at about $71,000. Bank of America Corp DE lifted its holdings in Pro-Dex by 173.3% in the 2nd quarter. Bank of America Corp DE now owns 1,692 shares of the medical instruments supplier’s stock valued at $74,000 after acquiring an additional 1,073 shares during the last quarter. Finally, Wells Fargo & Company MN lifted its holdings in Pro-Dex by 65.4% in the 4th quarter. Wells Fargo & Company MN now owns 2,314 shares of the medical instruments supplier’s stock valued at $89,000 after acquiring an additional 915 shares during the last quarter. 15.28% of the stock is owned by institutional investors and hedge funds.
About Pro-Dex
Pro-Dex, Inc is a designer and manufacturer of precision drive systems and fluid management products serving the dental, medical, industrial and energy markets. The company specializes in high-speed, brushless micromotors and controllers, as well as pneumatic and fluid control devices, providing both standard and custom-engineered solutions for original equipment manufacturers.
Its product portfolio includes high-speed dental handpieces, turbine systems, rotary and reciprocating micro-drives, along with integrated fluid delivery systems.
Featured Stories
- Five stocks we like better than Pro-Dex
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.
